15 August 2024

Eden Research Plc

("Eden" or "Company")

Appointment of new Head of Regulatory Affairs

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, is pleased to announce the appointment of Ilshad Moulan as the Company's new Head of Regulatory Affairs. Ilshad will bring his experience in the agrochemical sector to lead Eden Research's regulatory strategy and execution, helping to ensure the successful global registration of its innovative crop protection solutions. 

Ilshad has strong expertise in regulatory affairs management having led teams and managed complex projects across the industry. With a BSc degree in Biochemistry and Cell Biology and an MSc degree in Crop Protection and Regulatory Science, his strong scientific background complements his regulatory expertise.

At Dr. Knoell Consult Ltd, Ilshad led a team of nine, focusing on regulatory affairs. His career began at Agrauxine, where he played a key role in developing dossiers for biopesticide active ingredients and formulated plant protection products. Additionally, his previous roles at Evergreen Garden Care and Battelle involved supporting and managing regulatory submissions for conventional active ingredients and formulated products.

Ilshad Moulan commented:

"I am thrilled to join Eden Research at such an exciting time. I look forward to using my regulatory expertise to support Eden's mission of delivering sustainable solutions to the agricultural sector and ensuring our products reach farmers worldwide as quickly and efficiently as possible."

Ilshad will be based at Eden Research's headquarters in Oxfordshire and will begin his new role immediately. He succeeds Dr. Mike Carroll who will retire at the end of a handover period. Mike has served as Eden's first-ever regulatory leader and played a key role in not only establishing Eden's in-house regulatory capabilities, but in successfully expanding the regulatory authorisations for Eden's existing and new products. 

Sean Smith, CEO of Eden Research, added:

"We are delighted to welcome Ilshad to our team. His extensive background in regulatory affairs, combined with his leadership skills, will be a tremendous asset as we continue to navigate the complex regulatory landscape and bring our sustainable biopesticide products to market.  At the same time, we thank Mike for all of his contributions over the past four years.  His experience and leadership have been helpful in propelling our business forward and expanding our geographical footprint, and we are grateful for all his contributions. We wish Mike all the best for a long, happy retirement."

For further information contact:

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's seed treatment product, Ecovelex was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, U.S. and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

Eden's Sustaine^® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

​

For more information about Eden, please visit:  www.edenresearch.com.

ENDS